Literature DB >> 3661392

Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease.

R O Bonow1, S L Bacharach, M V Green, R L LaFreniere, S E Epstein.   

Abstract

Patients with coronary artery disease (CAD) may undergo periods of reversible myocardial ischemia without experiencing angina. To study the prognostic implications of "silent" myocardial ischemia induced by exercise, exercise electrocardiography and radionuclide angiography were performed in 131 consecutive patients with CAD, preserved left ventricular (LV) function at rest and mild or no symptoms during medical therapy. All patients who died during medical therapy were in the subgroup of patients with 3-vessel CAD in whom exercise-induced ischemia developed, which was characterized by both a decrease in LV ejection fraction and ST-segment depression. Patients in whom angina pectoris developed during exercise (54% of all patients) had a greater prevalence of this combined ischemic response to exercise than patients without angina (61% vs 27%, p less than 0.001) and also a greater prevalence of left main or 3-vessel CAD (59% vs 25%, p less than 0.001). However, when inducible ischemia was demonstrated, risk stratification and prognosis were the same whether the ischemic episode was symptomatic or silent. Among patients having both a reduction in ejection fraction and a positive ST-segment response, the likelihood of significant left main narrowing (13% vs 26%), 3-vessel CAD (56% vs 51%) and death during subsequent medical therapy (16% vs 9%) was similar in patients with silent compared to those with symptomatic ischemia. These data indicate that patients in whom angina develops during exercise have a greater prevalence of high-risk coronary anatomy and of inducible ischemia than patients without angina. However, once inducible ischemia is documented, the symptomatic response to exercise appears irrelevant for prognostic or risk stratification considerations.

Entities:  

Mesh:

Year:  1987        PMID: 3661392     DOI: 10.1016/0002-9149(87)91022-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 2.  Silent myocardial ischaemia.

Authors:  S Campbell
Journal:  BMJ       Date:  1988-09-24

Review 3.  [Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].

Authors:  D Hering; H P Schultheiss; D Horstkotte
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

4.  A new semiautomated algorithm to quantify Holter-detected myocardial ischemia: preliminary experience in the Trimetazidine European Multicenter trial (TEMS).

Authors:  J M Detry; R Fesler; T Berckmans; P Leclercq
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

5.  Prognostic significance of silent ischemia.

Authors:  S B Pancholy; B Schalet; V Kuhlmeier; V Cave; J Heo; A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

6.  Current treatment and future prospects for the management of acute coronary syndromes: consensus recommendations of the 1997 ushuaia conference, tierra del fuego, Argentina.

Authors:  E Gurfinkel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

7.  Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study.

Authors:  Jari A Laukkanen; Timo H Mäkikallio; Rainer Rauramaa; Sudhir Kurl
Journal:  Eur Heart J       Date:  2009-01-23       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.